血管ステントの世界市場：タイプ、材料、送達方法、製品、エンドユーザー別-2025-2030年予測

血管ステント市場は、2023年に213億4,000万米ドルと評価され、2024年には241億3,000万米ドルに達すると予測され、CAGR 13.54％で成長し、2030年には519億3,000万米ドルに達すると予測されています。

血管ステント市場には、狭窄または閉塞した血管の治療に使用される医療機器の開発と流通が含まれます。これらのステントは心血管系疾患の管理に不可欠であり、開口した動脈や静脈に必要不可欠なサポートを提供することで、適切な血流を確保します。ライフスタイルの変化や高齢化によって冠動脈疾患や末梢動脈疾患が増加しているため、医療処置における血管ステントの応用が重要になっています。最終用途部門には主に病院、外来手術センター、心臓専門センターなどがあり、低侵襲処置の進歩が市場の需要をさらに押し上げています。

この市場に影響を与える主な成長要因には、再狭窄率を低下させることで患者の予後を改善する薬剤溶出ステントなど、ステント設計における技術的進歩が含まれます。さらに、生体吸収性ステントと完全分解性ステント技術の統合は、将来的な技術革新の可能性を示しています。生活習慣病の有病率の増加、ヘルスケア支出の増加、血管合併症の早期介入に関する意識の高まりが、市場の需要をさらに押し上げています。しかし、高度なステント技術に伴う高コスト、規制上のハードル、ステント血栓症などの潜在的な合併症といった制約が、市場成長の課題となっています。

技術革新の機会は、生分解性ステントの開発と、個別化治療計画と患者モニタリングの改善のための人工知能の統合にあります。重要な研究分野は、多様な患者のニーズに応えるためにステントの生体適合性と機能性を高めることです。競争の激しい市場であるため、リーダーシップと市場関連性を維持するためには、新素材開発と非侵襲的治療法に焦点を当てた継続的な研究が必要です。企業は、製品の多様化と市場への浸透を高めるために、戦略的パートナーシップの活用と研究開発への投資を目指すべきです。手頃な価格への対応と有利な償還政策の確保も、特にヘルスケアインフラが整備されつつある新興市場において、より広範な普及を促進するために不可欠です。

市場力学：急速に進化する血管ステント市場の主要市場インサイトを公開

血管ステント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血管疾患の有病率の増加と老人人口の増加
  • 健康保険適用範囲の拡大により、外科手術がより身近に、
  • 低侵襲医療処置に対する需要の高まり
• 市場抑制要因
  • 代替医療の利用可能性と製品リコール
• 市場機会
  • 生体吸収性ステント開発への注目の高まり
  • 事業拡大のための共同戦略イニシアチブの増加
• 市場の課題
  • ステント導入に伴う合併症

ポーターの5つの力：血管ステント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血管ステント市場における外部からの影響の把握

外部マクロ環境要因は、血管ステント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血管ステント市場における競合情勢の把握

血管ステント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血管ステント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血管ステント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血管ステント市場における成功への道筋を描く

血管ステント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血管疾患の罹患率の増加と高齢者人口の増加
    • 健康保険の適用範囲が拡大し、外科手術がより受けやすくなる,
    • 低侵襲医療処置の需要増加
  • 抑制要因
    • 代替医療と製品リコールの利用可能性
  • 機会
    • 生体吸収性ステントの開発への注目が高まる
    • 事業拡大に向けた共同戦略イニシアチブの強化
  • 課題
    • ステント留置に伴う合併症
• 市場セグメンテーション分析
  • エンドユーザー：高品質のケアと迅速な回復のために外来手術センターで血管ステントを採用
  • 製品：跛行や四肢虚血などの合併症の予防のための腸骨ステントの利用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血管ステント市場：タイプ別

• ベアメタルステント
• バイオエンジニアリングステント
• 薬剤溶出ステント
• デュアルセラピーステント

第7章 血管ステント市場：素材別

• 金属ステント
• ポリマー

第8章 血管ステント市場配送方法別

• バルーン拡張型ステント
• 自己拡張型ステント

第9章 血管ステント市場：製品別

• 冠動脈ステント
• エバーステントグラフト
  • 腹部大動脈瘤
  • 胸部大動脈瘤
• 末梢ステント
  • 頸動脈ステント
  • 大腿ステント
  • 腸骨ステント
  • 腎動脈ステント

第10章 血管ステント市場：エンドユーザー別

• 外来手術センター
• 心臓センター
• 病院

第11章 南北アメリカの血管ステント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の血管ステント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの血管ステント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ボストン・サイエンティフィック、シルクロード・メディカル買収で血管ポートフォリオと長期的成長を強化
  • アボット、心臓病患者のケア強化のため、Xience Sierra冠動脈ステントシステムを発表
  • SMTとHeartXの戦略的提携により、世界中の先天性心疾患治療に革命を起こす
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Biosensors International Group, Ltd.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Medical, Inc
• CryoLife, Inc.
• Elixir Medical Corporation
• Endologix, Inc.
• Medtronic PLC
• Meril Life Sciences Pvt. Ltd
• Microport Scientific Corporation
• Purple Medical Solution Pvt. Ltd
• Sahajanand Medical Technologies Pvt. Ltd
• Stryker Corporation
• Terumo Corporation
• Veryan Medical Limited.
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. VASCULAR STENT MARKET RESEARCH PROCESS
• FIGURE 2. VASCULAR STENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VASCULAR STENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VASCULAR STENT MARKET DYNAMICS
• TABLE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY BIO-ENGINEERED STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY DUAL THERAPY STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY METALLIC STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VASCULAR STENT MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VASCULAR STENT MARKET SIZE, BY SELF-EXPANDING STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VASCULAR STENT MARKET SIZE, BY CORONARY STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VASCULAR STENT MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VASCULAR STENT MARKET SIZE, BY CAROTID STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VASCULAR STENT MARKET SIZE, BY FEMORAL STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VASCULAR STENT MARKET SIZE, BY ILIAC STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL VASCULAR STENT MARKET SIZE, BY RENAL ARTERY STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 58. CANADA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 59. CANADA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. CANADA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 61. CANADA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 62. CANADA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. CHINA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. CHINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 95. CHINA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 96. CHINA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. CHINA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 98. CHINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 99. CHINA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. INDIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. INDIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 102. INDIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 103. INDIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. INDIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 105. INDIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 106. INDIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. ITALY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. ITALY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 222. ITALY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 223. ITALY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. ITALY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 225. ITALY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 226. ITALY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 248. POLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 249. POLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 250. POLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 251. POLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 252. POLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 253. POLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 254. POLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 255. QATAR VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 256. QATAR VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 257. QATAR VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 258. QATAR VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. QATAR VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 260. QATAR VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 261. QATAR VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 325. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 326. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023

The Vascular Stent Market was valued at USD 21.34 billion in 2023, expected to reach USD 24.13 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 51.93 billion by 2030.

The vascular stent market encompasses the development and distribution of medical devices used to treat narrowed or blocked blood vessels. These stents are critical in managing cardiovascular diseases, offering essential support to open arteries and veins, thus ensuring proper blood flow. With increasing instances of coronary artery disease and peripheral artery disease, driven by lifestyle changes and growing aging populations, the application of vascular stents in medical procedures becomes crucial. End-use sectors primarily include hospitals, ambulatory surgical centers, and specialized cardiac centers, with a significant impetus from advancements in minimally invasive procedures further driving market demand.

Key growth factors influencing this market include technological advancements in stent design, such as drug-eluting stents, which enhance patient outcomes by reducing restenosis rates. Additionally, the integration of bioresorbable and fully degradable stent technologies showcases potential opportunities for future innovation. The increasing prevalence of lifestyle disorders, coupled with rising healthcare expenditures and awareness regarding early intervention in vascular complications, further propels market demand. However, limitations such as high costs associated with advanced stent technologies, regulatory hurdles, and potential complications such as stent thrombosis present challenges to market growth.

Innovation opportunities lie in developing biodegradable stents and integrating artificial intelligence for personalized treatment planning and improved patient monitoring. A key area for research is enhancing the biocompatibility and functionality of stents to cater to diverse patient needs. The competitive nature of the market necessitates continuous research, focusing on new material development and non-invasive treatment methods to maintain leadership and market relevance. Companies should aim to leverage strategic partnerships and investments in R&D for product diversification and to enhance market penetration. Addressing affordability and securing favorable reimbursement policies will also be vital to fostering broader adoption, especially in emerging markets with growing healthcare infrastructures.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Stent Market

The Vascular Stent Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of vascular diseases and growth in geriatric population
  • Expanding health insurance coverage makes surgical procedures more accessible,
  • Rising demand for minimally invasive medical procedures
• Market Restraints
  • Availability of alternative medical treatments and product recalls
• Market Opportunities
  • Rising focus on bioresorbable stents developments
  • Increasing collaborative strategic initiatives for business expansion
• Market Challenges
  • Complications associated with the stent implementation

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Stent Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Stent Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Stent Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Stent Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Stent Market

A detailed market share analysis in the Vascular Stent Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Stent Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Stent Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Stent Market

A strategic analysis of the Vascular Stent Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Inc, CryoLife, Inc., Elixir Medical Corporation, Endologix, Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd, Microport Scientific Corporation, Purple Medical Solution Pvt. Ltd, Sahajanand Medical Technologies Pvt. Ltd, Stryker Corporation, Terumo Corporation, Veryan Medical Limited., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Vascular Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Bare Metal Stent, Bio-Engineered Stent, Drug Eluting Stent, and Dual Therapy Stent.
• Based on Material, market is studied across Metallic Stent and Polymer.
• Based on Mode of Delivery, market is studied across Balloon-Expandable Stent and Self-Expanding Stent.
• Based on Product, market is studied across Coronary Stent, Evar Stent Graft, and Peripheral Stent. The Evar Stent Graft is further studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm. The Peripheral Stent is further studied across Carotid Stent, Femoral Stent, Iliac Stent, and Renal Artery Stent.
• Based on End-User, market is studied across Ambulatory Surgical Center, Cardiac Center, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of vascular diseases and growth in geriatric population
    • 5.1.1.2. Expanding health insurance coverage makes surgical procedures more accessible,
    • 5.1.1.3. Rising demand for minimally invasive medical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternative medical treatments and product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising focus on bioresorbable stents developments
    • 5.1.3.2. Increasing collaborative strategic initiatives for business expansion
  • 5.1.4. Challenges
    • 5.1.4.1. Complications associated with the stent implementation
• 5.2. Market Segmentation Analysis
  • 5.2.1. End-Users: Adoption of vascular stent in ambulatory surgical centers for high-quality care and rapid recovery
  • 5.2.2. Product: Utilisation of iliac stents for prevention of complications such as claudication and limb ischemia
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vascular Stent Market, by Type

• 6.1. Introduction
• 6.2. Bare Metal Stent
• 6.3. Bio-Engineered Stent
• 6.4. Drug Eluting Stent
• 6.5. Dual Therapy Stent

7. Vascular Stent Market, by Material

• 7.1. Introduction
• 7.2. Metallic Stent
• 7.3. Polymer

8. Vascular Stent Market, by Mode of Delivery

• 8.1. Introduction
• 8.2. Balloon-Expandable Stent
• 8.3. Self-Expanding Stent

9. Vascular Stent Market, by Product

• 9.1. Introduction
• 9.2. Coronary Stent
• 9.3. Evar Stent Graft
  • 9.3.1. Abdominal Aortic Aneurysm
  • 9.3.2. Thoracic Aortic Aneurysm
• 9.4. Peripheral Stent
  • 9.4.1. Carotid Stent
  • 9.4.2. Femoral Stent
  • 9.4.3. Iliac Stent
  • 9.4.4. Renal Artery Stent

10. Vascular Stent Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Center
• 10.3. Cardiac Center
• 10.4. Hospital

11. Americas Vascular Stent Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Vascular Stent Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Vascular Stent Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Boston Scientific to boost vascular portfolio and long-term growth with Silk Road Medical acquisition
  • 14.3.2. Abbott introduces Xience Sierra coronary stent system for enhanced heart patient care
  • 14.3.3. Strategic partnership between SMT and HeartX to revolutionize congenital heart defect treatment worldwide
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. B. Braun Melsungen AG
• 3. Becton, Dickinson and Company
• 4. Biosensors International Group, Ltd.
• 5. Biotronik SE & Co. KG
• 6. Boston Scientific Corporation
• 7. Cook Medical, Inc
• 8. CryoLife, Inc.
• 9. Elixir Medical Corporation
• 10. Endologix, Inc.
• 11. Medtronic PLC
• 12. Meril Life Sciences Pvt. Ltd
• 13. Microport Scientific Corporation
• 14. Purple Medical Solution Pvt. Ltd
• 15. Sahajanand Medical Technologies Pvt. Ltd
• 16. Stryker Corporation
• 17. Terumo Corporation
• 18. Veryan Medical Limited.
• 19. W. L. Gore & Associates, Inc.